Drugs & Targets FDA grants accelerated approval to Elahere for platinum-resistant ovarian cancer November 18, 2022Vol.48 No.42
Drugs & Targets Lynparza receives positive CHMP opinion for metastatic, castration-resistant prostate cancer November 18, 2022Vol.48 No.42
Drugs & Targets Fox Chase, Oryzon Genomics collaborate on Iadademstat clinical trial November 18, 2022Vol.48 No.42
Drugs & Targets MD Anderson, Exscientia collaborate to develop oncology treatments using AI November 18, 2022Vol.48 No.42
Drugs & Targets FDA approves Imjudo + Imfinzi and platinum-based chemo for metastatic NSCLC November 11, 2022Vol.48 No.41
Drugs & Targets FDA approves Adcetris + chemo for pediatric classical Hodgkin lymphoma November 11, 2022Vol.48 No.41
Drugs & Targets Portage Biotech, Merck to collaborate on clinical trial November 11, 2022Vol.48 No.41
Drugs & Targets FDA issues draft guidance on expanded access to investigational drugs November 04, 2022Vol.48 No.40
